BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37884686)

  • 21. Psoralen photochemotherapy.
    McClelland PB; Morgan P; Leach EE; Shelk J
    Dermatol Nurs; 1997 Dec; 9(6):403-15; quiz 416-7. PubMed ID: 9460332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
    Niemi KM; Niemi A; Kanerva L
    Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.
    Wang XM; McNiff JM; Klump V; Asgari M; Gasparro FP
    Photochem Photobiol; 1997 Aug; 66(2):294-9. PubMed ID: 9277151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of psoralen plus UV-A therapy in the autonomous community of Valencia, Spain].
    Grau-Salvat C; Vilata-Corell JJ; Azón-Massoliver A; Pérez-Ferriols A
    Actas Dermosifiliogr; 2007 Nov; 98(9):611-6. PubMed ID: 17961450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathology of remodelling induced by PUVA in the superficial dermis.
    Pierard GE; Ackerman AB
    Br J Dermatol; 1979 Mar; 100(3):251-6. PubMed ID: 435383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
    Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoralen and ultraviolet a light therapy for psoriasis.
    Stern RS
    N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
    [No Abstract]   [Full Text] [Related]  

  • 30. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
    Alshiyab D; Chin MF; Edwards C; Anstey AV
    Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis.
    Dawe RS; Cameron H; Yule S; Man I; Wainwright NJ; Ibbotson SH; Ferguson J
    Br J Dermatol; 2003 Jun; 148(6):1194-204. PubMed ID: 12828749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bullous pemphigoid. Occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation.
    Abel EA; Bennett A
    Arch Dermatol; 1979 Aug; 115(8):988-9. PubMed ID: 380470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins in PUVA-treated psoriasis.
    Heiligstädt H; Kassis B; Weismann K; Søndergaad J
    Acta Derm Venereol; 1978; 58(3):213-6. PubMed ID: 78634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
    Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
    Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoralen/UVA treatment and chromosomes. II. Analyses of psoriasis patients.
    Brøgger A; Waksvik H; Thune P
    Arch Dermatol Res; 1978 May; 261(3):287-94. PubMed ID: 686812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PUVA (psoralen + UVA) photochemotherapy: processes triggered in the cells.
    Zarebska Z; Waszkowska E; Caffieri S; Dall'Acqua F
    Farmaco; 2000 Aug; 55(8):515-20. PubMed ID: 11132728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis.
    de Berker DA; Sakuntabhai A; Diffey BL; Matthews JN; Farr PM
    J Am Acad Dermatol; 1997 Apr; 36(4):577-81. PubMed ID: 9092744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Woronoff's rings with PUVA therapy.
    Warin AP; Greaves MW
    Arch Dermatol; 1979 Jan; 115(1):105. PubMed ID: 760643
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.